Somewhat Positive News Coverage Somewhat Unlikely to Affect National Health Investors (NHI) Share Price

Media coverage about National Health Investors (NYSE:NHI) has been trending somewhat positive on Friday, Accern Sentiment Analysis reports. Accern identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. National Health Investors earned a news impact score of 0.19 on Accern’s scale. Accern also gave news headlines about the real estate investment trust an impact score of 45.8813320659881 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

National Health Investors opened at $74.50 on Friday, according to Marketbeat.com. National Health Investors has a 52 week low of $62.71 and a 52 week high of $81.60. The firm has a market cap of $3.07 billion, a PE ratio of 13.98, a PEG ratio of 3.84 and a beta of 0.46. The company has a quick ratio of 15.21, a current ratio of 15.21 and a debt-to-equity ratio of 0.88.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Tuesday, May 8th. The real estate investment trust reported $0.92 EPS for the quarter, missing the consensus estimate of $1.34 by ($0.42). National Health Investors had a return on equity of 11.69% and a net margin of 53.88%. The firm had revenue of $72.75 million for the quarter, compared to analysts’ expectations of $72.04 million. During the same quarter in the prior year, the business earned $1.25 earnings per share. The company’s quarterly revenue was up 9.6% on a year-over-year basis. equities research analysts predict that National Health Investors will post 5.5 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, August 10th. Stockholders of record on Friday, June 29th will be given a dividend of $1.00 per share. The ex-dividend date is Thursday, June 28th. This represents a $4.00 annualized dividend and a dividend yield of 5.37%. National Health Investors’s dividend payout ratio is currently 75.05%.

NHI has been the subject of several recent analyst reports. SunTrust Banks set a $70.00 target price on National Health Investors and gave the stock a “hold” rating in a research note on Saturday, February 17th. They noted that the move was a valuation call. Stifel Nicolaus set a $76.00 target price on National Health Investors and gave the stock a “buy” rating in a research note on Saturday, February 17th. Mizuho reissued a “hold” rating and set a $70.00 target price on shares of National Health Investors in a research note on Monday, February 26th. Hilliard Lyons raised National Health Investors from a “neutral” rating to a “buy” rating in a research note on Friday, February 16th. Finally, KeyCorp cut their target price on National Health Investors from $70.00 to $60.00 and set a “sell” rating for the company in a research note on Tuesday, April 17th. One analyst has rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $73.44.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Insider Buying and Selling by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply